Phase I Trial With Expansion Cohort of DNA-PK Inhibition and IMRT in Cisplatin-Ineligible Patients With Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
For more information about the trial above please contact the study team:
Principal Investigator, John Kaczmar, at firstname.lastname@example.org, or please call +1 843-792-6691.
Study Coordinator, Carly Fecio, at email@example.com.
Trial opened at the following institutions: Medical University of South Carolina